Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 10847 record(s)

Req # A-2021-00036

All records for the broadband funding applications of the companies mentioned, including but not limited to letters, briefing notes, emails, presentations, related to meetings held only in May 2021 and June 2021 between representatives from the CRTC and representatives from any and all of the following: BCE Inc., Rogers Communications, Telus Corp., and Shaw communications.

Organization: Canadian Radio-television and Telecommunications Commission

118 page(s)
March 2024

Req # A-2023-00037

All relevant documents regarding: - estimated or actual revenues: in total and/or in Canada - estimated or actual program sales: in total and/or in Canada - estimated or actual advertising revenues: in total and/or in Canada - estimated or actual expenditures: in total and/or in Canada - estimated or actual Canadian programming expenditures: in total and/or in Canada - estimated or actual number of subscriptions: in total and/or in Canada - estimated or actual subscriber revenue: in total and or in Canada - estimated or actual employment: in total and/or in Canada - estimated or actual hours tuned: in total and/or in Canada - estimated or actual uploads or downloads: in total and/or in Canada.

Organization: Canadian Radio-television and Telecommunications Commission

209 page(s)
March 2024

Req # A-2023-00039

For the period from 1 January 2005 to 21 September 2023, all documents held by the CRTC which deal with "Service Standards".

Organization: Canadian Radio-television and Telecommunications Commission

97 page(s)
March 2024

Req # A-2023-00055

Please provide the number of undertakings and the total full-time/equivalent staffing for conventional private radio stations for each of the broadcast years from 2013/2014 to 2021/2022, for each of the following regions: - Atlantic - Quebec - Ontario - Prairies and - BC & Territories

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
March 2024

Req # A-2023-00058

A copy of the agreement between the CRTC and the CTAL on a moratorium or any agreement between its two parties.

Organization: Canadian Radio-television and Telecommunications Commission

0 page(s)
March 2024

Req # A-2016-000420

Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.

Organization: Health Canada

299 page(s)
March 2024

Req # A-2019-001464

All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.

Organization: Health Canada

3917 page(s)
March 2024

Req # A-2019-001525

The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.

Organization: Health Canada

898 page(s)
March 2024

Req # A-2020-001374

For the period 2015 to April 19, 2021, and in relation to natural health product brand names containing the phrase “glucosamine sulfate” or “glucosamine sulphate”, with license holders named WN Pharmaceuticals Ltd, Natural Factors Nutritional Products Limited, or Jamieson Laboratories Inc., the following documents. All product licences, and the specifications to which the natural health product will comply. All applications for a product licence, correspondences with respect to those applications, and the attestations by the applicants that the product will be manufactured and distributed in accordance with good manufacturing practices. All testing done of the product, and correspondences made in relation to the testing of the product. All correspondences between the Minister and a licensee, manufacturer, importer or distributer to stop their sale of the product. All correspondences in relation to labelling and packaging of the product; and all complaints of non-compliance in respect of the product. For the period May 6, 2004 to April 19, 2021, all monographs of “glucosamine sulfate” and “glucosamine hydrochloride”

Organization: Health Canada

1565 page(s)
March 2024

Req # A-2021-001830

A summary of the costs incurred to develop, advertise, and run the COVID Alert App program mentioned in this news story: https://globalnews.ca/news/8478550/attempts-improve-covid-alert-stall-lack-of-interest-provinces/. Records from the start of the program to January 21, 2022.

Organization: Health Canada

15 page(s)
March 2024
Date modified: